Ophthalmic Pathology Fellowship

Retinoblastoma

Overview

Ophthalmic pathology expertise is in great demand at academic medical centers with the increase in specialized clinical eye institutes and increasingly sophisticated surgical and medical treatments for eye diseases. At Stanford, we offer a unique fellowship program in ophthalmic pathology that provides cutting-edge training in diagnosis of eye diseases from ocular, orbital, and adnexal biopsies and surgeries. Our program draws upon the wealth of ophthalmic surgeries performed at the Stanford Hospital, Byers Eye Institute, and VA Palo Alto Healthcare System.  Our program receives advanced consultative material from private hospitals, medical examiners, as well as major VA hospitals throughout California (Greater Los Angeles VA network, VA San Diego, VA Long Beach, etc). These provide comprehensive exposure to virtually all types of ocular tissue specimens, surgeries, and pathology manifestations of eye diseases. These also provide an unparalleled range of tissue-based research opportunities to investigate the cellular and molecular pathomechanisms of eye diseases. The Ophthalmic Pathology Fellowship is an ACGME-accredited program.

The ophthalmic pathology fellows will have opportunities for learning in a multidisciplinary setting from colleagues in other specialties of ophthalmology and pathology. Graduated responsibility opportunities include a Junior Attending rotation, presenting at tumor boards, teaching opportunities, and service as a point person and consultant on eye-pathology-related issues.

Significant elective and research time is provided during the fellowship for fellows to explore scientific and translational research interests.  The Departments of Pathology and Ophthalmology also provide extensive support and resources for fellows who wish to develop independent research programs.  Electives include ophthalmic specialties (cornea, ocular oncology, oculoplastics, glaucoma) and pathology subspecialties (neuropathology, dermatopathology, molecular pathology). Additional electives can be arranged to support the fellows' career goals.   

The fellowship accepts up to 2 fellows/year. Applicants with pathology or ophthalmology training are welcome and will be supported by Department of Pathology or Ophthalmology (depending on the candidate's background).

Enucleation Melanoma

Temporal Arteritis

Temporal Arteritis Giant Cells

Flexner-Wintersteiner

Rotations

During the 1-year fellowship, ophthalmic pathology fellows will spend
their time seeing cases at the following sites including:

  • Stanford Hospital
  • Lucille Packard Children's Hospital
  • Byers Eye Institute
  • VA Palo Alto
  • Research
  • Elective
  • Vacation & Education Conferences/Meetings

Uveal Melanoma Enucleation

Deadlines

Each year we accept applications for fellowship positions to start the following July. Interviews will occur in early Fall.

Applying

We accept applications one-year prior to start of the fellowship. Fellowship positions are available for
July 1, 2021 and July 1, 2022.

Please submit application & required documents to: Gabby Barela. Letters of Recommendation are to be sent directly by the office of the referee providing the recommendation. Letters of Recommendation may be emailed directly to: eyepathology@stanfordhealthcare.org or, they can be mailed to the following address:

Gabby Barela
Ophthalmic Pathology Fellowship Coordinator
Email: gbarela@stanford.edu 

Fellowship Coordinator

Gabby Barela
Email: gbarela@stanford.edu

Ophthalmic Pathology Faculty

Jonathan Lin, MD, PhD

Professor of Pathology and of Ophthalmology
Director, Ophthalmic Pathology Service
Director, Ophthalmic Fellowship Program

Dr. Jonathan Lin specializes in ophthalmic pathology.  As Director of Eye Pathology, he oversees the operations of the service, participates in multidisciplinary management on diagnosis and treatment of ocular diseases, and directs training of residents and fellows on the service. In addition to serving as Professor of Pathology and Ophthalmology, he has an NIH and VA supported research program investigating retinal cell biology and neurodegeneration diseases. He is active in multiple national organizations, including Association for Research in Vision and Ophthalmology (ARVO), Society for Neuroscience (SfN), and United States and Canadian Academy of Pathology (USCAP).